Withings, the French consumer electronics brand, has FDA approval for its upcoming smart scale, the Body Scan. This scale appears ordinary but is loaded with biosensors for comprehensive health insights. It features a 6-lead ECG array, notably detecting atrial fibrillation (A-Fib), an arrhythmic heart activity. Withings introduced the world’s first smartwatch with built-in ECG sensors in 2019.
The Body Scan’s ECG module also measures nerve activity through sweat gland analysis in the feet, giving personalized insights in under 20 seconds. It calculates vascular age, heart rate, and calorie burn rate. Priced at $399.95, it offers segmental body composition assessment via Bioelectrical Impedance Analysis (BIA), analyzing water, fat, muscle, and bone mass for the whole body and specific parts. All these measurements are taken within three seconds through the handgrip. This comprehensive analysis aids athletes and those with muscle-related issues in diagnosis and recovery.
